[
    "{\"step_by_step_thinking\": \"To determine the most recent oral direct thrombin inhibitor (DTI) for acute stroke prevention, we need to review the information provided in the relevant documents. From the documents, we can see that ximelagatran was mentioned as a DTI that has been studied and approved for certain indications. However, it was also mentioned that ximelagatran has been withdrawn from the market due to safety concerns. On the other hand, dabigatran was mentioned as an oral DTI that has gained approval for stroke prevention in patients with atrial fibrillation. Based on this information, the most recent oral DTI for acute stroke prevention is dabigatran.\", \"answer_choice\": \"C\"}"
]